Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 16-19, 2025 | Boston, MA

    Learn More
    BIO Asia-Taiwan
    BioSafe General Membership Meeting

    April 7-9, 2025
    Basel, Switzerland

    BIO Investor Forum
    Partnering @JPM Week

    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO CEO & Investor Conference

    Miami, FL | 2026

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3099 results found
Expand All
Apply All
3099 results found

Happy 40th, Bayh-Dole!
Share
Good Day BIO Newsletter  •  December 14, 2020
It’s a happy Monday indeed with Pfizer-BioNTech vaccine doses on their way to every U.S. state and territory. Meanwhile, ICYMI in the midst of all the vaccine excitement, Bayh-Dole turned 40 and Congress passed the defense spending bill with a boost for the bioeconomy. (1,000 words, 5 minutes)
Read More

FDA panel recommends authorization of Pfizer-BioNTech vaccine
Share
Good Day BIO Newsletter  •  December 11, 2020
It’s Friday. Congress is working to avoid a government shutdown today. Meanwhile, we have a recap of yesterday’s FDA advisory committee meeting on the Pfizer-BioNTech vaccine as well as details of a new group working to advance Black professionals in the agriculture industry. (727 words, 3 minutes, 38 seconds)
Read More

What to know ahead of FDA’s Pfizer/BioNTech meeting
Share
Good Day BIO Newsletter  •  December 10, 2020
We preview today’s FDA meeting about the Pfizer/BioNTech COVID-19 vaccine. And believe it or not, the holiday season is here. If you still have some shopping to do, we give you ideas for sustainable, biobased gifts for everyone on your list. (863 words, 4 minutes, 18 seconds)
Read More

BIO Submits Comments on Final EPA PIP rule
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  December 9, 2020
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant-incorporated protectants (PIPs).1 In particular, EPA’s proposed revisions would create an exemption from certain requirements of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Federal Food, Drug, and Cosmetic Act (FFDCA) for PIPs based upon sexually compatible plants developed using biotechnology.    
Read More

This bill would boost renewable chemicals and build resilience
Share
Good Day BIO Newsletter  •  December 9, 2020
Today, we applaud a new bill that would boost renewable chemicals and the bioeconomy and explain why it’s not too late to get a flu vaccine. (724 words, 3 minutes, 37 seconds)
Read More

BIO challenges “Most Favored Nation” drug pricing plan
Share
Good Day BIO Newsletter  •  December 8, 2020
It’s another busy day in Washington. In the meantime, we have details on our legal challenge to the Trump administration’s drug pricing plan, as well as a look at a new report on the health impacts of climate change and how sustainable biobased fuels can help. (850 words, 4 minutes, 15 seconds)
Read More

CDC’s COVID vaccine chief: no safety corners cut
Share
Good Day BIO Newsletter  •  December 7, 2020
It’s a busy Monday. BIO’s Dr. Michelle McMurry-Heath talked with the CDC’s Dr. Nancy Messonnier about the safety and efficacy of the COVID-19 vaccines. Also, we look at the House leadership selections that will impact climate and the bioeconomy, including some historic “firsts.” (900 words, 4 minutes, 30 seconds)
Read More

BIO & Covid Vaccine Facts
Share

IP Webinar Recording Request - Thank You
Share
Policy

New Website Will Combat Vaccine Myths, Boost Public Confidence, Increase Acceptance
Share
Vaccines  •  Press Release  •  December 4, 2020
Public opinion polls show there is significant mistrust among the American public in the safety and efficacy of vaccines. So today, the Biotechnology Innovation Organization (BIO) announced the launch of COVIDVaccineFacts.org. As a subsidiary website of BIO, COVIDVaccineFacts.org is an educational tool that links healthcare providers and the public to scientific and evidenced-based information related to the vaccine development process. Vaccine safety, efficacy, availability, and affordability are among the topics covered on the website. On the website, which is translated in English and Spanish, users will find answers to a number of “frequently asked questions” related to vaccine development, including: What is a vaccine? How are vaccines developed? How is everyone moving so quickly to develop a vaccine for Covid-19? How will we know a Covid-19 vaccine is safe and effective? When will my family and I receive a vaccine for Covid-19? BIO will continue to update the website and add new questions in the coming months. The text on this website has been independently reviewed by health experts. It also incorporates several visual elements to help explain concepts like herd immunity, emergency use authorization, and more. Dr. Michelle McMurry-Heath, BIO’s president and CEO, made the following remarks on the new website: “Our biopharma companies have made incredible progress in finding vaccines and other scientific solutions we need to end this pandemic. “However, developing vaccines is only part of the battle. We will not find relief from this pandemic unless we ensure all families and communities have access to vaccines – and have confidence in taking them. “We hope the COVIDVaccineFacts.org will serve as a unique and comprehensive resource to educate the public on the scientifically rigorous, transparent, and safety-focused vaccine development process to build trust in our industry’s unprecedented response to this pandemic.” Click here to visit the…
Read More
covid-19

Pagination

  • First First page
  • Prev Previous page
  • …
  • 200
  • 201
  • 202
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO